In MLH1 methylated ovarian and colon cancer xenografts, cancer cells were sensitized to carboplatin, cisplatin, TMZ and epirubicin after re-expression of MLH1 by decitabine [127]. This evidence concerns the gene MLH1 and colonic neoplasm.